Aniracetam
Title: Aniracetam
CAS Registry Number: 72432-10-1
CAS Name: 1-(4-Methoxybenzoyl)-2-pyrrolidinone
Additional Names: 1-p-anisoyl-2-pyrrolidinone
Manufacturers' Codes: Ro-13-5057
Trademarks: Draganon (Roche); Sarpul (Roche)
Molecular Formula: C12H13NO3
Molecular Weight: 219.24
Percent Composition: C 65.74%, H 5.98%, N 6.39%, O 21.89%
Literature References: Cognition enhancer related to piracetam, q.v. Prepn: JP Kokai 79 117468; E. Kyburz, W. Aschwanden, US 4369139 (1979, 1983 both to Hoffmann-La Roche). Effects on learning and memory in rats: R. Cumin et al., Psychopharmacology 78, 104 (1982); K. Yamada et al., Pharmacol. Biochem. Behav. 22, 645 (1985); in monkeys and pigeons: M. J. Pontecorvo, H. L. Evans, ibid. 745. Clinical evaluation in geriatric patients: P. Foltyn et al., Arzneim.-Forsch. 33, 865 (1983); in Alzheimer's disease: L. B. Sourander et al., Psychopharmacology 91, 90 (1987). Review of toxicology: B. Schläppi et al., Drug Invest. 5, Suppl. 1, 50-67 (1993).
Properties: Crystals from ethanol, mp 121-122°. LD50 in rats, mice (mg/kg): ~4500, >5000 orally (Cumin).
Melting point: mp 121-122°
Toxicity data: LD50 in rats, mice (mg/kg): ~4500, >5000 orally (Cumin)
Therap-Cat: Nootropic.
Keywords: Nootropic.

Others monographs:
ErdinPotassium Thioantimonate(V)Sulfur TrioxideMecoprop
DimoxylineSesamolinβ-PhellandreneIsobutylene
Q-EnzymeTorularhodinEpanololNitromersol
Cesium BromideTrimeprazineBarium OxideBepotastine
©2016 DrugLead US FDA&EMEA